Positron emission tomography in the diagnosis of mesothelioma.

[1]  Edward F Patz,et al.  The role of imaging in malignant pleural mesothelioma. , 2002, Seminars in oncology.

[2]  A. Alavi,et al.  Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  D. Sugarbaker,et al.  Malignant pleural mesothelioma. , 2001, Cancer treatment and research.

[4]  R. Hawkins,et al.  Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma. , 2000, The Journal of thoracic and cardiovascular surgery.

[5]  F. Fazio,et al.  18-FDG positron emission tomography in the evaluation of malignant pleural diseases - a pilot study. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[6]  A. Alavi,et al.  Prognostic value of FDG PET imaging in malignant pleural mesothelioma. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  H. Schirrmeister,et al.  [F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes]. , 1999, NuclearMedicine.

[8]  A. Alavi,et al.  Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. , 1998, Chest.

[9]  G. Brix,et al.  Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinase , 1998, Gene Therapy.

[10]  G. van Kaick,et al.  FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. , 1994, Nuclear medicine and biology.

[11]  G van Kaick,et al.  Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  G. van Kaick,et al.  PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  Kazutomo Inoue,et al.  Over-expression of facilitative glucose transporter genes in human cancer. , 1990, Biochemical and biophysical research communications.